Levels of unbound selvigaltin below galectin-3 KD have demonstrated significant efficacy on a range of biomarkers of MASH and fibrosis, showing that high concentrations in excess of KD are not required for activity. The gene discussed is LGALS3; the disease is metabolic dysfunction-associated steatohepatitis.